1
|
Vahekeni N, Brillatz T, Rahmaty M, Cal M, Keller-Maerki S, Rocchetti R, Kaiser M, Sax S, Mattli K, Wolfram E, Marcourt L, Queiroz EF, Wolfender JL, Mäser P. Antiprotozoal Activity of Plants Used in the Management of Sleeping Sickness in Angola and Bioactivity-Guided Fractionation of Brasenia schreberi J.F.Gmel and Nymphaea lotus L. Active against T. b. rhodesiense. Molecules 2024; 29:1611. [PMID: 38611890 PMCID: PMC11013945 DOI: 10.3390/molecules29071611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2024] [Revised: 03/20/2024] [Accepted: 03/22/2024] [Indexed: 04/14/2024] Open
Abstract
Folk medicine is widely used in Angola, even for human African trypanosomiasis (sleeping sickness) in spite of the fact that the reference treatment is available for free. Aiming to validate herbal remedies in use, we selected nine medicinal plants and assessed their antitrypanosomal activity. A total of 122 extracts were prepared using different plant parts and solvents. A total of 15 extracts from seven different plants exhibited in vitro activity (>70% at 20 µg/mL) against Trypanosoma brucei rhodesiense bloodstream forms. The dichloromethane extract of Nymphaea lotus (leaves and leaflets) and the ethanolic extract of Brasenia schreberi (leaves) had IC50 values ≤ 10 µg/mL. These two aquatic plants are of particular interest. They are being co-applied in the form of a decoction of leaves because they are considered by local healers as male and female of the same species, the ethnotaxon "longa dia simbi". Bioassay-guided fractionation led to the identification of eight active molecules: gallic acid (IC50 0.5 µg/mL), methyl gallate (IC50 1.1 µg/mL), 2,3,4,6-tetragalloyl-glucopyranoside, ethyl gallate (IC50 0.5 µg/mL), 1,2,3,4,6-pentagalloyl-β-glucopyranoside (IC50 20 µg/mL), gossypetin-7-O-β-glucopyranoside (IC50 5.5 µg/mL), and hypolaetin-7-O-glucoside (IC50 5.7 µg/mL) in B. schreberi, and 5-[(8Z,11Z,14Z)-heptadeca-8,11,14-trienyl] resorcinol (IC50 5.3 µg/mL) not described to date in N. lotus. Five of these active constituents were detected in the traditional preparation. This work provides the first evidence for the ethnomedicinal use of these plants in the management of sleeping sickness in Angola.
Collapse
Affiliation(s)
- Nina Vahekeni
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Théo Brillatz
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Marjan Rahmaty
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Monica Cal
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Sonja Keller-Maerki
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Romina Rocchetti
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Marcel Kaiser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Sibylle Sax
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Kevin Mattli
- Phytopharmacy & Natural Products, Institute of Chemistry and Biotechnology, Zürich University of Applied Sciences (ZHAW), 8820 Wädenswil, Switzerland (E.W.)
| | - Evelyn Wolfram
- Phytopharmacy & Natural Products, Institute of Chemistry and Biotechnology, Zürich University of Applied Sciences (ZHAW), 8820 Wädenswil, Switzerland (E.W.)
| | - Laurence Marcourt
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Emerson Ferreira Queiroz
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Jean-Luc Wolfender
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Pascal Mäser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| |
Collapse
|
2
|
Kamal N, Mio Asni NS, Rozlan INA, Mohd Azmi MAH, Mazlan NW, Mediani A, Baharum SN, Latip J, Assaw S, Edrada-Ebel RA. Traditional Medicinal Uses, Phytochemistry, Biological Properties, and Health Applications of Vitex sp. PLANTS (BASEL, SWITZERLAND) 2022; 11:plants11151944. [PMID: 35893648 PMCID: PMC9370779 DOI: 10.3390/plants11151944] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Revised: 07/20/2022] [Accepted: 07/21/2022] [Indexed: 06/13/2023]
Abstract
The genus Vitex is also known as a chaste tree, in which it is a large shrub native to the tropical and subtropical regions of the world. A diverse range of species is distributed throughout Southern Europe, the Mediterranean, and Central Asia. The Vitex tree, including its leaves and fruits, has been used for herbal remedies in the form of pastes, decoctions, and dried fruits since ancient times. This article aimed to prepare a comprehensive review of traditional uses and secondary metabolites derived from Vitex sp., including the chemical compounds, biological activities, application of Vitex in human clinical trials, toxicology and safety, marketed products, and patents. The scientific findings were obtained using a number of search engines and databases, including Google Scholar, PMC, and ScienceDirect. Vitex species are well known in pharmacology to have medicinal values, such as anti-inflammatory, antibacterial, antifungal, antimicrobial, antioxidant, and anticancer properties. Previous studies reported that some species are proven to be effective in treating diseases, such as diabetes, and improving female health. A total of 161 compounds from different Vitex species are reported, covering the literature from 1982 to 2022. A chemical analysis report of various studies identified that Vitex exhibited a wide range of phytoconstituents, such as iridoid, diterpenoid, ecdysteroid, and flavonoid and phenolic compounds. Apart from that, the review will also discuss the application of Vitex in human clinical trials, toxicology and safety, marketed products, and patents of the genus. While the extracts of the genus have been made into many commercial products, including supplements and essential oils, most of them are made to be used by women to improve menstrual conditions and relieve premenstrual syndrome. Among the species, Vitex agnus-castus L. is the only one that has been reported to undergo clinical trials, mainly related to the use of the genus for the treatment of mastalgia, menstrual bleeding problems, amenorrhea, menorrhagia, luteal insufficiency, and premenstrual syndrome. Overall, the review addresses recent therapeutic breakthroughs and identifies research gaps that should be explored for prospective research work.
Collapse
Affiliation(s)
- Nurkhalida Kamal
- Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia; (N.S.M.A.); (I.N.A.R.); (A.M.); (S.N.B.)
| | - Nurul Syahidah Mio Asni
- Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia; (N.S.M.A.); (I.N.A.R.); (A.M.); (S.N.B.)
| | - Ivana Nur Allisya Rozlan
- Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia; (N.S.M.A.); (I.N.A.R.); (A.M.); (S.N.B.)
| | - Muhammad Aniq Hamzah Mohd Azmi
- Analytical and Environmental Chemistry Unit, Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus 21030, Malaysia;
| | - Noor Wini Mazlan
- Analytical and Environmental Chemistry Unit, Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus 21030, Malaysia;
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Nerus 21030, Malaysia;
| | - Ahmed Mediani
- Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia; (N.S.M.A.); (I.N.A.R.); (A.M.); (S.N.B.)
| | - Syarul Nataqain Baharum
- Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia; (N.S.M.A.); (I.N.A.R.); (A.M.); (S.N.B.)
| | - Jalifah Latip
- Department of Chemistry, Faculty of Science and Technology, Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia;
| | - Suvik Assaw
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Nerus 21030, Malaysia;
- Marine Biology Unit, Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus 21030, Malaysia
| | - Ru Angelie Edrada-Ebel
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde (SIPBS), The John Arbuthnott Building, 161 Cathedral Street, Glasgow G4 0RE, UK;
| |
Collapse
|
3
|
Das N, Salgueiro ACF, Choudhury DR, Mandal SK, Logesh R, Hassan MM, Devkota HP. Traditional uses, phytochemistry, and pharmacology of genus Vitex (Lamiaceae). Phytother Res 2022; 36:571-671. [PMID: 35172042 DOI: 10.1002/ptr.7330] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 10/13/2021] [Accepted: 10/23/2021] [Indexed: 11/06/2022]
Abstract
Vitex, the genus of the family Lamiaceae, comprises of about 230 species mostly distributed in the warm regions of Europe and temperate regions of Asia. Several Vitex species have been used as folk medicine in different countries for the treatment of various kinds of diseases and ailments. The main aim of this review is to collect and analyze the scientific information available about the Vitex species regarding their chemical constituents and pharmacological activities. The phytochemical investigation of various Vitex species has resulted in the isolation of about 556 chemical constituents belong to various chemical category viz. iridoids, diterpenoids, triterpenoids, flavonoids, lignans, sesquiterpenoids, monoterpenoids, ecdysteroids, and others. The crude extracts of different Vitex species as well as pure phytochemicals exhibited a wide spectrum of in-vitro and in-vivo pharmacological activities. In the present review, the scientific literature data on the ethnopharmacological, phytochemical, and pharmacological investigations on the genus Vitex are summarized. More attention should be given in future research to evaluate the pharmacological potential with detailed mechanism of actions for the pure compounds, extracts of plants from this genus. Moreover, their clinical study is needed to justify their use in modern medicine and to further exploring this genus for new drug discovery.
Collapse
Affiliation(s)
- Niranjan Das
- Department of Chemistry, Iswar Chandra Vidyasagar College, Belonia, India
| | | | | | - Sudip Kumar Mandal
- Department of Pharmaceutical Chemistry, Dr. B. C. Roy College of Pharmacy & Allied Health Sciences, Durgapur, India
| | - Rajan Logesh
- TIFAC-CORE in Herbal Drugs, Department of Pharmacognosy and Phytopharmacy, JSS College of Pharmacy, Ooty, India
| | - Md Mahadi Hassan
- Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Hari Prasad Devkota
- Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| |
Collapse
|
4
|
Borgo J, Laurella LC, Martini F, Catalán CAN, Sülsen VP. Stevia Genus: Phytochemistry and Biological Activities Update. Molecules 2021; 26:2733. [PMID: 34066562 PMCID: PMC8125113 DOI: 10.3390/molecules26092733] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Revised: 04/28/2021] [Accepted: 04/30/2021] [Indexed: 12/12/2022] Open
Abstract
The Stevia genus (Asteraceae) comprises around 230 species, distributed from the southern United States to the South American Andean region. Stevia rebaudiana, a Paraguayan herb that produces an intensely sweet diterpene glycoside called stevioside, is the most relevant member of this genus. Apart from S. rebaudiana, many other species belonging to the Stevia genus are considered medicinal and have been popularly used to treat different ailments. The members from this genus produce sesquiterpene lactones, diterpenes, longipinanes, and flavonoids as the main types of phytochemicals. Many pharmacological activities have been described for Stevia extracts and isolated compounds, antioxidant, antiparasitic, antiviral, anti-inflammatory, and antiproliferative activities being the most frequently mentioned. This review aims to present an update of the Stevia genus covering ethnobotanical aspects and traditional uses, phytochemistry, and biological activities of the extracts and isolated compounds.
Collapse
Affiliation(s)
- Jimena Borgo
- Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET—Universidad de Buenos Aires, Buenos Aires 1113, Argentina; (J.B.); (L.C.L.); (F.M.)
- Cátedra de Farmacognosia, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
- Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
| | - Laura C. Laurella
- Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET—Universidad de Buenos Aires, Buenos Aires 1113, Argentina; (J.B.); (L.C.L.); (F.M.)
- Cátedra de Farmacognosia, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
| | - Florencia Martini
- Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET—Universidad de Buenos Aires, Buenos Aires 1113, Argentina; (J.B.); (L.C.L.); (F.M.)
- Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
| | - Cesar A. N. Catalán
- Instituto de Química Orgánica, Facultad de Bioquímica Química y Farmacia, Universidad Nacional de Tucumán, Ayacucho 471 (T4000INI), San Miguel de Tucumán T4000, Argentina;
| | - Valeria P. Sülsen
- Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET—Universidad de Buenos Aires, Buenos Aires 1113, Argentina; (J.B.); (L.C.L.); (F.M.)
- Cátedra de Farmacognosia, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
- Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
| |
Collapse
|
5
|
Ungogo MA, Ebiloma GU, Ichoron N, Igoli JO, de Koning HP, Balogun EO. A Review of the Antimalarial, Antitrypanosomal, and Antileishmanial Activities of Natural Compounds Isolated From Nigerian Flora. Front Chem 2020; 8:617448. [PMID: 33425860 PMCID: PMC7786139 DOI: 10.3389/fchem.2020.617448] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 12/03/2020] [Indexed: 12/16/2022] Open
Abstract
The West African country Nigeria features highly diverse vegetation and climatic conditions that range from rain forest bordering the Atlantic Ocean in the South to the Desert (Sahara) at the Northern extreme. Based on data from the World Conservation Monitoring Center of the United Nations Environmental Protection, Nigeria, with ~5,000 documented vascular plants, ranks amongst the top 50 countries in terms of biodiversity. Such a rich biodiversity implies that the country is rich in diverse secondary metabolites-natural products/unique chemicals produced by the plant kingdom to confer selective advantages to them. Like many tropical countries, Nigeria is also endemic to numerous infectious diseases particularly those caused by parasitic pathogens. These phytochemicals have been exploited for the treatment of diseases and as a result, a new branch of chemistry, natural product chemistry, has evolved, to try to reproduce and improve the therapeutic qualities of particular phytochemicals. In this review, we have compiled a compendium of natural products, isolated from Nigerian flora, that have been reported to be effective against certain protozoan parasites with the aim that it will stimulate interests for further investigations, and give impetus to the development of the natural products into registered drugs. In total 93 structurally characterized natural compounds have been identified with various levels of anti-parasite activity mainly from Nigerian plants. The synthesis protocol and molecular target for some of these natural anti-parasite agents have been established. For instance, the anti-plasmodial compound fagaronine (7), a benzophenanthridine alkaloid from Fagara zanthoxyloides has been successfully synthesized in the laboratory, and the anti-trypanosomal compound azaanthraquinone (55) elicits its effect by inhibiting mitochondrial electron transfer in trypanosomes. This review also discusses the barriers to developing approved drugs from phytochemicals, and the steps that should be taken in order to accelerate the development of new antiparasitics from the highlighted compounds.
Collapse
Affiliation(s)
- Marzuq A. Ungogo
- Department of Veterinary Pharmacology and Toxicology, Ahmadu Bello University, Zaria, Nigeria
- College of Medical, Veterinary and Life Sciences, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
| | - Godwin U. Ebiloma
- School of Health and Life Sciences, Teesside University, Middlesbrough, United Kingdom
| | - Nahandoo Ichoron
- Phytochemistry Research Group, Department of Chemistry, University of Agriculture, Makurdi, Nigeria
| | - John O. Igoli
- Phytochemistry Research Group, Department of Chemistry, University of Agriculture, Makurdi, Nigeria
| | - Harry P. de Koning
- College of Medical, Veterinary and Life Sciences, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
| | - Emmanuel O. Balogun
- Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria
- Africa Centre of Excellence for Neglected Tropical Diseases and Forensic Biotechnology (ACENTDFB), Ahmadu Bello University, Zaria, Nigeria
| |
Collapse
|
6
|
Mofidi Tabatabaei S, Moridi Farimani M, Nejad-Ebrahimi S, Salehi P. Phytochemical Study of Tanacetum Sonbolii Aerial Parts and the Antiprotozoal Activity of its Components. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH : IJPR 2020; 19:77-83. [PMID: 32922471 PMCID: PMC7462493 DOI: 10.22037/ijpr.2020.1100951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The genus Tanacetum includes some popular endemic species of the flora of Iran, with important medicinal properties. In a project, directed at structurally interesting bioactive metabolites from Iranian endemic species, we studied Tanacetum sonbolii Mozaff. Eight compounds comprising six phenolic and two terpenoidal compounds were isolated from the ethyl acetate extract of the aerial parts of the plant by normal and reverse phase chromatography. Their structures were established mainly by 1D and 2D NMR spectroscopic techniques, including 1H-1H COSY, HSQC and HMBC methods and confirmed by comparing their NMR data with those reported in the literature. The compounds namely: 2,4-dihydroxy-6-methoxyacetophenone (1), apigenin (2), 5-desmethylsinensetin (3), 5-desmethylnobiletin (4), 8-methoxycirsilineol (5), scopoletin (6), ursolic acid (7), and β-sitosterol (8). In-vitro antiprotozoal activity of compounds 1, 3, and 5 were evaluated against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani and Plasmodium falciparum parasites and also toxicity against rat myoblast (L6) cells. Compound 5 showed promising activity against T. b. rhodesiense.
Collapse
Affiliation(s)
- Sahar Mofidi Tabatabaei
- Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran, Iran
| | - Mahdi Moridi Farimani
- Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran, Iran
| | - Samad Nejad-Ebrahimi
- Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran, Iran
| | - Peyman Salehi
- Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran, Iran
| |
Collapse
|
7
|
Wang KW, Zhang TT. Bioactive Flavonoids from Verbenaceae. MINI-REV ORG CHEM 2020. [DOI: 10.2174/1570193x16666191007170602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Flavonoids are widely distributed in the plant kingdom and possess a variety of biological
activities, such as anti-oxidant, anti-inflammatory, and anti-viral activities. Due to the structural diversity
and biological activity, flavonoid derivatives isolated from Verbenaceae family have received
a lot of attention by the research scholars. In this paper, a total of 150 natural flavonoids isolated
from Verbenaceae and their bioactivities were summarized.
Collapse
Affiliation(s)
- Kui-Wu Wang
- Department of Applied Chemistry, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, China
| | - Ting-Ting Zhang
- Department of Applied Chemistry, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, China
| |
Collapse
|
8
|
Vahekeni N, Neto PM, Kayimbo MK, Mäser P, Josenando T, da Costa E, Falquet J, van Eeuwijk P. Use of herbal remedies in the management of sleeping sickness in four northern provinces of Angola. JOURNAL OF ETHNOPHARMACOLOGY 2020; 256:112382. [PMID: 31743767 DOI: 10.1016/j.jep.2019.112382] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2019] [Revised: 11/02/2019] [Accepted: 11/10/2019] [Indexed: 06/10/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE This study reports for the first time on the use of folk medicine to treat sleeping sickness and its symptoms in four endemic provinces in northern Angola. By interviewing both traditional practitioners and confirmed patients, it highlights reasons to recourse to folk medicine, the plant species used for this affection as well as arises awareness about the use of particular plants showing potential risks. AIM OF THE STUDY The aims of this explorative study were three-fold. Firstly, it informed on access to, and use of plant-based medicine as first-choice treatment by infected persons. Secondly, it aimed at collecting comprehensive data from patients and traditional healers on herbal remedies in order to identify plant species used in the management of the disease. Thirdly, it served as contribution for primary indication of potential risk of use associated with the studied plants and their preparation. MATERIALS AND METHODS The study was conducted in 4 endemic provinces of Angola, namely Bengo, Zaire, Kwanza Norte and Uíge. We explored the use of herbal remedies by conducting structured and semi-structured interviews within two distinct study populations. The first group comprises 30 patients who had been diagnosed for trypanosomiasis and treated by the reference treatment. The second group included 9 traditional practitioners who had already treated sleeping sickness. The plants that were cited during the interviews were collected during field walks under supervision of a traditional healer, then authenticated and deposited at the National Herbarium in Luanda. RESULTS Of the 30 included patients, 12 (40%) had turned to folk medicine in the management of trypanosomiasis and related symptoms. 7 medicinal plants were reported by this group. Considering the key motivation to consult a traditional practitioner, two main factors accounted for half of the cases: "past experience with folk medicine" and "family habit". Out of 9 traditional practitioners' interviewees, 26 medicinal plants were cited. Roots and leaves were the most used plant parts, and decoction was the common mode of preparation. Evidence for antitrypanosomal activity in the scientific literature was found for 56% (17 of 30) of the identified plant species. The most cited plant was Crossopteryx febrifuga (UR = 6). Some of the cited plants, as for example Aristolochia gigantea, raised concern about potential toxicity. CONCLUSIONS With 40% of infected persons having turned first to folk medicine before consulting a medical doctor, this explorative study points out that plant-based medicines play an important role in local dynamics of health care. It highlights the need for primary assessment of potential risk of use related to the herbal recipes, and for reporting it to the concerned population. This first ethnobotanical study on trypanosomiasis in endemic provinces of Angola provides information on 30 plants, of which some had been identified as promising for further pharmacological research. Our results provide a first step towards the validation and valorization of Angolan herbal remedies for sleeping sickness.
Collapse
Affiliation(s)
- Nina Vahekeni
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland; Nacional Center of Scientific Investigation (CNIC), Luanda, Angola.
| | - Pedro Menezes Neto
- Centro de Estudos e Investigação Científica de Botânica, Universidade Agostinho Neto, Luanda, Angola.
| | | | - Pascal Mäser
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
| | - Théophile Josenando
- Instituto de Combate e Controlo das Tripanossomíasses (ICCT), Luanda, Angola.
| | - Esperança da Costa
- Centro de Estudos e Investigação Científica de Botânica, Universidade Agostinho Neto, Luanda, Angola.
| | | | - Peter van Eeuwijk
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland; Institute of Social Anthropology, University of Basel, Münsterplatz 19, 4051, Basel, Switzerland.
| |
Collapse
|
9
|
Sass G, Tsamo AT, Chounda GAM, Nangmo PK, Sayed N, Bozzi A, Wu JC, Nkengfack AE, Stevens DA. Vismione B Interferes with Trypanosoma cruzi Infection of Vero Cells and Human Stem Cell-Derived Cardiomyocytes. Am J Trop Med Hyg 2020; 101:1359-1368. [PMID: 31571568 DOI: 10.4269/ajtmh.19-0350] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Traditional African medicine is a source of new molecules that might be useful in modern therapeutics. We tested ten limonoids, six quinones, one xanthone, one alkaloid, and one cycloartane, isolated from four Cameroonian medicinal plants, and one plant-associated endophytic fungus, against Trypanosoma cruzi, the etiological agent of Chagas disease (CD). Vero cells, or human-induced pluripotent stem cells (hiPSC)-derived cardiomyocytes (hiPSC-CM) were infected with T. cruzi trypomastigotes (discrete typing unit types I or II). Infection took place in the presence of drugs, or 24 hours before drug treatment. Forty-eight hours after infection, infection rates and parasite multiplication were evaluated by Giemsa stain. Cell metabolism was measured to determine functional integrity. In Vero cells, several individual molecules significantly affected T. cruzi infection and multiplication with no, or minor, effects on cell viability. Reduced infection rates and multiplication by the quinone vismione B was superior to the commonly used therapeutic benznidazole (BNZ). The vismione B concentration inhibiting 50% of T. cruzi infection (IC50) was 1.3 µM. When drug was applied after infection, anti-Trypanosoma effects of vismione B [10 µM) were significantly stronger than effects of BNZ (23 µM). Furthermore, in hiPSC-CM cultures, infection and multiplication rates in the presence of vismione B (10 µM) were significantly lower than in BNZ (11.5 µM), without showing signs of cytotoxicity. Our data indicate that vismione B is more potent against T. cruzi infection and multiplication than BNZ, with stronger effects on established infection. Vismione B, therefore, might become a promising lead molecule for treatment development for CD.
Collapse
Affiliation(s)
- Gabriele Sass
- California Institute for Medical Research, San Jose, California
| | - Armelle T Tsamo
- Department of Organic Chemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon
| | - Gwladys A M Chounda
- Department of Organic Chemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon
| | - Pamela K Nangmo
- Department of Organic Chemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon
| | - Nazish Sayed
- Department of Radiology, School of Medicine, Stanford University, Stanford, California.,Division of Cardiology, Department of Medicine, School of Medicine, Stanford University, Stanford, California.,Institute of Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, California.,Department of Medicine, School of Medicine, Stanford University, Stanford, California
| | - Adriana Bozzi
- California Institute for Medical Research, San Jose, California.,Division of Cardiology, Department of Medicine, School of Medicine, Stanford University, Stanford, California.,Institute of Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, California.,Institute of Research René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil.,Department of Medicine, School of Medicine, Stanford University, Stanford, California.,Department of Radiology, School of Medicine, Stanford University, Stanford, California
| | - Joseph C Wu
- Division of Cardiology, Department of Medicine, School of Medicine, Stanford University, Stanford, California.,Department of Radiology, School of Medicine, Stanford University, Stanford, California.,Institute of Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, California.,Department of Medicine, School of Medicine, Stanford University, Stanford, California
| | - Augustin E Nkengfack
- Department of Organic Chemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon
| | - David A Stevens
- Institute of Research René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil.,California Institute for Medical Research, San Jose, California
| |
Collapse
|
10
|
Boniface PK, Elizabeth FI. Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery. Curr Drug Targets 2019; 20:1295-1314. [PMID: 31215385 DOI: 10.2174/1389450120666190618114857] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2019] [Revised: 05/28/2019] [Accepted: 05/31/2019] [Indexed: 01/04/2023]
Abstract
BACKGROUND Human African Trypanosomiasis (HAT), also known as sleeping sickness is one of the 20 neglected tropical diseases listed by the World Health Organization, which lead to death if left untreated. This disease is caused by Trypanosoma brucei gambiense, which is the chronic form of the disease present in western and central Africa, and by T. brucei rhodesiense, which is the acute form of the disease located in eastern and southern Africa. Many reports have highlighted the effectiveness of flavonoid-based compounds against T. brucei. OBJECTIVE The present review summarizes the current standings and perspectives for the use of flavonoids as lead compounds for the potential treatment of HAT. METHODS A literature search was conducted for naturally occurring and synthetic anti-T brucei flavonoids by referencing textbooks and scientific databases (SciFinder, PubMed, Science Direct, Wiley, ACS, SciELO, Google Scholar, Springer, among others) from their inception until February 2019. RESULTS Flavonoids isolated from different parts of plants and species were reported to exhibit moderate to high in vitro antitrypanosomal activity against T. brucei. In addition, synthetic flavonoids revealed anti-T. brucei activity. Molecular interactions of bioactive flavonoids with T. brucei protein targets showed promising results. CONCLUSION According to in vitro anti-T brucei studies, there is evidence that flavonoids might be lead compounds for the potential treatment of HAT. However, toxicological studies, as well as the mechanism of action of the in vitro active flavonoids are needed to support their use as potential leads for the treatment of HAT.
Collapse
Affiliation(s)
- Pone Kamdem Boniface
- Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil
| | - Ferreira Igne Elizabeth
- Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil
| |
Collapse
|
11
|
Gill BS, Mehra R, Navgeet, Kumar S. Vitex negundo and its medicinal value. Mol Biol Rep 2018; 45:2925-2934. [PMID: 30311123 DOI: 10.1007/s11033-018-4421-3] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Accepted: 10/04/2018] [Indexed: 12/28/2022]
Abstract
Natural products are rich in several potent bioactive compounds, targeting complex network of proteins involved in various diseases. Vitex negundo (VN), commonly known as "chaste tree", is an ethnobotanically important plant with enormous medicinal properties. Different species of Vitex vary in chemical composition, thus producing different phytochemicals. Several bioactive compounds have been extracted from leaves, seeds, roots in form of volatile oils, flavonoids, lignans, iridoids, terpenes, and steroids. These bioactive compounds exhibit anti-inflammatory, antioxidant, antidiabetic, anticancer, antimicrobial. VN is typically known for its role in the modulation of cellular events like apoptosis, cell cycle, motility of sperms, polycystic ovary disease, and menstrual cycle. VN, reportedly, perturbs many cancer-signaling pathways involving p-p38, p-ERK1/2, and p-JNK in LPS-elicited cells, N-terminal kinase (JNK), COX-1 pathways, MAPK, NF-κB, tumor necrosis factor α (TNF-α), Akt, mTOR, vascular endothelial growth factor, hypoxia-inducible factor (HIF-1α). Several bioactive compounds obtained from VN have been commercialized and others are under investigation. This is the first review presenting up-to-date information about the VN, its bioactive constituents and their mode of action.
Collapse
Affiliation(s)
- Balraj Singh Gill
- Department of Biosciences, Central University of Punjab, Bathinda, India.,Department of Higher Education Himachal Pradesh, Shimla, Himachal Pradesh, India
| | - Richa Mehra
- Department of Biosciences, Central University of Punjab, Bathinda, India
| | - Navgeet
- Department of Biotechnology, KMV College, Jalandhar, Punjab, India.
| | - Sanjeev Kumar
- Department of Plant Sciences, Central University of Punjab, Bathinda, India.
| |
Collapse
|
12
|
Simoben CV, Ntie-Kang F, Akone SH, Sippl W. Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis. NATURAL PRODUCTS AND BIOPROSPECTING 2018; 8:151-169. [PMID: 29744736 PMCID: PMC5971035 DOI: 10.1007/s13659-018-0165-y] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2018] [Accepted: 04/26/2018] [Indexed: 05/10/2023]
Abstract
Parasitic diseases continue to represent a threat on a global scale, particularly among the poorest countries in the world. This is particularly because of the absence of vaccines, and in some cases, resistance against available drugs, currently being used for their treatment. In this review emphasis is laid on natural products and scaffolds from African medicinal plants (AMPs) for lead drug discovery and possible further development of drugs for the treatment of parasitic diseases. In the discussion, emphasis has been laid on alkaloids, terpenoids, quinones, flavonoids and narrower compound classes of compounds with micromolar range activities against Schistosoma, Trypanosoma and Leishmania species. In each subparagraph, emphasis is laid on the compound subclasses with most promising in vitro and/or in vivo activities of plant extracts and isolated compounds. Suggestions for future drug development from African medicinal plants have also been provided. This review covering 167 references, including 82 compounds, provides information published within two decades (1997-2017).
Collapse
Affiliation(s)
- Conrad V Simoben
- Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg, Wolfgang-Langenbeck-Str. 4, 06120, Halle (Saale), Germany
| | - Fidele Ntie-Kang
- Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg, Wolfgang-Langenbeck-Str. 4, 06120, Halle (Saale), Germany.
- Department of Chemistry, Faculty of Science, University of Buea, P.O. Box 63, Buea, 00237, Cameroon.
| | - Sergi H Akone
- Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-University, Universitaetsstrasse1, Geb. 26.23, Duesseldorf, 40225, Germany
- Department of Chemistry, Faculty of Science, University of Douala, PO Box 24157, Douala, 00237, Cameroon
| | - Wolfgang Sippl
- Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg, Wolfgang-Langenbeck-Str. 4, 06120, Halle (Saale), Germany
| |
Collapse
|
13
|
Silva MLAE, Pereira AC, Ferreira DS, Esperandim VR, Símaro GV, Lima TC, Januário AH, Pauletti PM, Rehder VLG, Crevelin EJ, Cunha WR, Crotti AEM, Bastos JK. In vitro
Activities of Pfaffia glomerata
Root Extract, Its Hydrolyzed Fractions and Pfaffic Acid Against Trypanosoma cruzi
Trypomastigotes. Chem Biodivers 2017; 14. [DOI: 10.1002/cbdv.201600175] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2016] [Accepted: 08/19/2016] [Indexed: 11/07/2022]
Affiliation(s)
- Márcio L. A. e Silva
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Ana C. Pereira
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
- School of Pharmaceutical Sciences of Ribeirão Preto; University of São Paulo; Ribeirão Preto SP Brazil
| | - Daniele S. Ferreira
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Viviane R. Esperandim
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Guilherme V. Símaro
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Thaís C. Lima
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Ana H. Januário
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Patrícia M. Pauletti
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Vera L. G. Rehder
- Centro Pluridisciplinar de Pesquisas Químicas Biológicas e Agrícolas-CPQBA/UNICAMP; Campinas SP Brazil
| | - Eduardo J. Crevelin
- Departamento de Química; Faculdade de Filosofia; Ciências e Letras de Ribeirão Preto; Universidade de São Paulo; Ribeirão Preto SP Brazil
| | - Wilson R. Cunha
- Núcleo de Pesquisas em Ciências Exatas e Tecnológicas; Universidade de Franca; Av. Dr. Armando Sales de Oliveira, 201 - Parque Universitário Franca SP CEP 14404-600 Brazil
| | - Antônio E. M. Crotti
- Departamento de Química; Faculdade de Filosofia; Ciências e Letras de Ribeirão Preto; Universidade de São Paulo; Ribeirão Preto SP Brazil
| | - Jairo K. Bastos
- School of Pharmaceutical Sciences of Ribeirão Preto; University of São Paulo; Ribeirão Preto SP Brazil
| |
Collapse
|
14
|
Killing of Trypanozoon Parasites by the Equine Cathelicidin eCATH1. Antimicrob Agents Chemother 2016; 60:2610-9. [PMID: 26824936 DOI: 10.1128/aac.01127-15] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2015] [Accepted: 01/06/2016] [Indexed: 12/27/2022] Open
Abstract
Trypanozoon parasites infect both humans, causing sleeping sickness, and animals, causing nagana, surra, and dourine. Control of nagana and surra depends to a great extent on chemotherapy. However, drug resistance to several of the front-line drugs is rising. Furthermore, there is no official treatment for dourine. Therefore, there is an urgent need to develop antiparasitic agents with novel modes of action. Host defense peptides have recently gained attention as promising candidates. We have previously reported that one such peptide, the equine antimicrobial peptide eCATH1, is highly active against equine Gram-positive and Gram-negative bacteria, without cytotoxicity against mammalian cells at bacteriolytic concentrations. In the present study, we show that eCATH1 exhibits an in vitro 50% inhibitory concentration (IC50) of 9.5 μM against Trypanosoma brucei brucei, Trypanosoma evansi, and Trypanosoma equiperdum Its trypanocidal mechanism involves plasma membrane permeabilization and mitochondrial alteration based on the following data: (i) eCATH1 induces the rapid influx of the vital dye SYTOX Green; (ii) it rapidly disrupts mitochondrial membrane potential, as revealed by immunofluorescence microscopy using the fluorescent dye rhodamine 123; (iii) it severely damages the membrane and intracellular structures of the parasites as early as 15 min after exposure at 9.5 μM and 5 min after exposure at higher concentrations (19 μM), as evidenced by scanning and transmission electron microscopy. We also demonstrate that administration of eCATH1 at a dose of 10 mg/kg to T. equiperdum-infected mice delays mortality. Taken together, our findings suggest that eCATH1 is an interesting template for the development of novel therapeutic agents in the treatment of trypanosome infections.
Collapse
|
15
|
Nwodo NJ, Ibezim A, Ntie-Kang F, Adikwu MU, Mbah CJ. Anti-trypanosomal activity of nigerian plants and their constituents. Molecules 2015; 20:7750-71. [PMID: 25927903 PMCID: PMC6272792 DOI: 10.3390/molecules20057750] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2014] [Revised: 04/17/2015] [Accepted: 04/22/2015] [Indexed: 12/27/2022] Open
Abstract
African trypanosomiasis is a vector-borne parasitic disease causing serious risks to the lives of about 60 million people and 48 million cattle globally. Nigerian medicinal plants are known to contain a large variety of chemical structures and some of the plant extracts have been screened for antitrypanosomal activity, in the search for potential new drugs against the illness. We surveyed the literatures on plants and plant-derived products with antitrypanosomal activity from Nigerian flora published from 1990 to 2014. About 90 plants were identified, with 54 compounds as potential active agents and presented by plant families in alphabetical order. This review indicates that the Nigerian flora may be suitable as a starting point in searching for new and more efficient trypanocidal molecules.
Collapse
Affiliation(s)
- Ngozi Justina Nwodo
- Department of Pharmaceutical and Medicinal Chemistry, University of Nigeria, Nsukka 410001, Nigeria.
| | - Akachukwu Ibezim
- Department of Pharmaceutical and Medicinal Chemistry, University of Nigeria, Nsukka 410001, Nigeria.
| | - Fidele Ntie-Kang
- Department of Chemistry, Chemical and Bioactivity Information Centre, Faculty of Science, University of Buea, P.O. Box 63, Buea 00237, Cameroon.
| | | | - Chika John Mbah
- Department of Pharmaceutical and Medicinal Chemistry, University of Nigeria, Nsukka 410001, Nigeria.
| |
Collapse
|